Top Markets
Coin of the day
Catalent, Inc. Catalent, Inc.

Catalent, Inc.

CTLT
주식 순위 #1926
Catalent, Inc., operating globally through its various subsidiaries,... Catalent, Inc., operating globally through its various subsidiaries, specializes in the development and production of comprehensive solutions for a wide array of products, including pharmaceutical drugs, protein-based biologics, advanced cell and gene therapies, and consumer health items. The company's operations are strategically divided into four key segments: Biologics; Softgel and Oral Technologies; Oral and Specialty Delivery; and Clinical Supply Services. The Softgel and Oral Technologies division focuses on the formulation, development, and manufacturing of soft capsules. These are utilized in a diverse range of client products, such as prescription medications, over-the-counter drugs, nutritional supplements, unit-dose cosmetics, and medicinal preparations for animal health. Within the Biologics segment, Catalent undertakes the creation of biologic cell lines, develops and manufactures both cell therapy and viral-based gene therapy, and handles the formulation and production of parenteral dose forms, including vials, prefilled syringes, and cartridges. This segment also provides essential analytical development and testing capabilities. The Oral and Specialty Delivery segment offers extensive formulation, development, and manufacturing expertise across various technologies. It provides integrated downstream solutions spanning clinical development and commercial supply. This segment also features a dedicated oral delivery solutions platform, encompassing preclinical screening, formulation, analytical development, and current good manufacturing practices (cGMP) services. Finally, the Clinical Supply Services segment delivers vital support for drug and biologic clinical trials. Its services include manufacturing, specialized packaging, secure storage, efficient distribution, and comprehensive inventory management. This segment also offers "FastChain," a demand-led clinical supply service. Catalent serves a broad client base, including pharmaceutical, biotechnology, and consumer health organizations, alongside companies in other healthcare sectors like animal health and medical devices, and even the cosmetics industry. The company was founded in 2007 and maintains its headquarters in Somerset, New Jersey.
주가
$63.48
마지막 동기화: 2024-12-17
시가총액
$11.52B
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Catalent, Inc. (CTLT)

카테고리

B의 시가 총액을 가진 CTLT의 가격
Catalent, Inc. Catalent, Inc.
CTLT
$63.48
의 시가총액 Catalent, Inc.(CTLT)
시가총액: $11.52B
August 2026 기준으로 Catalent, Inc.의 시가총액은 $11.52B입니다. 이는 당사 데이터에 따르면 Catalent, Inc.이 세계에서 1926th번째로 가치 있는 기업임을 의미합니다. 시가총액은 상장된 회사의 발행 주식 총 시장 가치를 의미하며, 일반적으로 회사의 가치를 측정하는 데 사용됩니다.
2014부터 2026까지 Catalent, Inc.의 시가총액 기록
CTLT 가장 인기있는 상위 5 가지 stocks과 비교하여
CTLT의 가격 자산 b b의 시장 결과
Catalent, Inc. Catalent, Inc.
$27,838.96 $11.52B
$5.053T +43,754.70%
Catalent, Inc. Catalent, Inc.
$25,146.49 $11.52B
$4.564T +39,513.25%
Catalent, Inc. Catalent, Inc.
$23,114.19 $11.52B
$4.196T +36,311.77%
Catalent, Inc. Catalent, Inc.
$19,993.66 $11.52B
$3.629T +31,396.00%
Catalent, Inc. Catalent, Inc.
$15,543.14 $11.52B
$2.821T +24,385.09%